Stay updated on Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page

  1. Check
    8 days ago
    No Change Detected
  2. Check
    15 days ago
    Change Detected
    Summary
    Added a new Locations section and entry for Beijing Municipality; the old Beijing Municipality Locations label was removed and the page now shows Revision: v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T07:56:36.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.1 to v3.3.2 in the page footer.
    Difference
    0.1%
    Check dated 2025-12-01T16:17:31.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Revision: v3.3.1 added and v3.2.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T11:13:22.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Removal of the general government funding and operating-status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:10:11.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    No additions or deletions were detected between the two screenshots; the page content appears unchanged. The page continues to present study details for NCT04695470.
    Difference
    0.5%
    Check dated 2025-11-03T00:46:32.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    4%
    Check dated 2025-10-05T07:14:18.000Z thumbnail image

Stay in the know with updates to Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page.